Delivery Order SPE2DB22D3011-SPE2DB25FQ2TD
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Solu-Medrol 1 gram vials, with a ceiling value of $3,636.56. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Solu-Medrol 40 mg vials valued at $5,223.67 with a firm fixed price structure. The contract, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $1,265.88 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, for the supply of Solu-Medrol 500 mg vials. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,986.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 125 mg vials of Solu-Medrol. As the prime contractor, Amerisourcebergen will deliver the corticosteroid drug to its place of performance in Conshohocken, Pennsylvania by September 6, 2023 under the terms of the award. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to supply drugs and medical supplies to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Solu-Medrol 125 mg vials, with a ceiling value of $6,564.16 and an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The product will be delivered to the vendor's corporate office...
- The Defense Logistics Agency Troop Support Medical awarded a $128,870 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 125 mg vials of Solu-Medrol. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order is for a one day period of performance spanning August 14 to August 15, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for SOLU-MEDROL 1 gram vials valued at $3,330.42. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,281.64 on July 24, 2025, for the supply of Solu-Medrol 1 gram vials under a firm fixed price contract. This non-competitive delivery order, with an ultimate completion date of July 25, 2025, was funded by the Medical Supply Chain, the pharmaceutical procurement arm of the Defense Logistics Agency. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $6,127.81 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 14, 2025. The award fulfills pharmaceutical supply requirements with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of SOLU-MEDROL 2,000 mg vials. This non-set-aside, firm fixed-price delivery order has a ceiling value of $1,002.48 and an ultimate completion date of July 14, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2TDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 mg vials of Solu-Medrol, a corticosteroid medication commonly used for anti-inflammatory and immunosuppressant purposes in military and federal healthcare settings. This firm fixed-price delivery order, valued at $1,475.83, was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen provides comprehensive pharmaceutical and medical supply support to military healthcare systems, the Defense Health Agency, and other federal healthcare organizations. The company's established role as a critical pharmaceutical distributor ensures consistent availability of essential medications and medical commodities across federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/15/25 |